Luye Pharma Group (HK:2186) has released an update.
Luye Pharma Group Ltd. successfully conducted its annual general meeting (AGM) on May 28, 2024, with all resolutions passed by a substantial majority, including the adoption of financial statements, re-election of directors, and re-appointment of Ernst & Young as the auditor. Shareholders also granted the board general mandates to manage share issuances and repurchases, reflecting strong investor confidence in the company’s governance.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
